Anti-Stromal interaction molecule 1 抗体 [5A2]
Anti-Stromal interaction molecule 1 antibody [5A2]
4
(11 Reviews)
|
(19 Publications)
Mouse Monoclonal Stromal interaction molecule 1 antibody. Suitable for ICC, IP, Flow Cyt, WB, IHC-P, ICC/IF and reacts with Human samples. Cited in 19 publications. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human STIM1.
別名を表示する
GOK, STIM1, Stromal interaction molecule 1
- ICC/IF
AbReview20217****
Immunocytochemistry/ Immunofluorescence - Anti-Stromal interaction molecule 1 antibody [5A2] (AB57834)
ab57834 staining the stromal interaction molecule in HeLa cells by immunocytochemistry/immunofluorescence (ICC/IF). Cells were fixed with paraformaldehyde and permeabilized with 0.5% TritonX. Samples were incubated with primary antibody (1/200) for 1 hour at 24°C. An Alexa Fluor ® 488-conjugated chicken anti-mouse polyclonal (1/1000) was used as the secondary.
This image was generated using the ascites version of the product.
This image is courtesy of an anonymous Abreview
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Stromal interaction molecule 1 antibody [5A2] (AB57834)
ab57834 at 10 ug/ml staining Stromal interaction molecule 1 in human Hella cells by Immunocytochemistry/ Immunofluorescence.
This image was generated using the ascites version of the product.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Stromal interaction molecule 1 antibody [5A2] (AB57834)
Stromal interaction molecule 1 antibody (ab57834) used in immunohistochemistry at 3ug/ml on formalin fixed and paraffin embedded human malignant lymphoma, diffuse large B.
This image was generated using the ascites version of the product.
- Flow Cyt
Unknown
Flow Cytometry - Anti-Stromal interaction molecule 1 antibody [5A2] (AB57834)
Overlay histogram showing HeLa cells stained with ab57834 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab57834, 0.5μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG2a [ICIGG2A] (ab91361, 1μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed.
This image was generated using the ascites version of the product.
- WB
Unknown
Western blot - Anti-Stromal interaction molecule 1 antibody [5A2] (AB57834)
Stromal interaction molecule 1 antibody (ab57834) at 1ug/lane + HeLa cell lysate at 25ug/lane.
This image was generated using the ascites version of the product.
All lanes:
Western blot - Anti-Stromal interaction molecule 1 antibody [5A2] (ab57834)
Predicted band size: 77 kDa
false
- WB
CiteAb
Western blot - Anti-Stromal interaction molecule 1 antibody [5A2] (AB57834)
Stromal interaction molecule 1 western blot using anti-Stromal interaction molecule 1 antibody [5A2] ab57834. Publication image and figure legend from Uysal-Onganer, P., MacLatchy, A., et al., 2020, Int J Mol Sci, PubMed 32098295.
ab57834 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab57834 please see the product overview.
PAD2 and PAD4 isozyme-specific inhibitor 1 h treatment affects prohibitin (PHB), stromal interaction molecule 1 (STIM-1) and moesin protein levels in LN18 and LN229 GBM cell lines. (A) PHB protein levels in LN18 and LN229 cells, respectively, following 1 h treatment with the PAD2 and PAD4 inhibitors, compared to control-treated cells. (B) STIM-1 protein levels in LN18 and LN229 cells respectively, following 1 h treatment with the PAD2 and PAD4 inhibitors, compared to control-treated cells. (C) Moesin protein levels in LN18 and LN229 cells, respectively, following 1 h treatment with the PAD2 and PAD4 inhibitors, compared to control-treated cells. Representative blots are shown; the density ratios of the various proteins analysed and actin are presented as normalised quantified data (mean ±S.D.) for treatment with the PAD2 and PAD4 specific inhibitors, compared to DMSO treated controls. The corresponding molecular weight size standard is indicated in kilodaltons (kDa) on each blot. Exact p-values are indicated, error bars show SD (* indicates significant differences with p < 0.05; n = 3 biological replicates for all).
false
Reactivity data
製品の詳細
出荷温度及び保存条件
製品の状態
精製度
バッファー組成
出荷温度
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
STIM1 plays a critical role in the store-operated calcium entry (SOCE) mechanism a significant process in cellular calcium signaling. STIM1 senses calcium concentration within the endoplasmic reticulum and upon depletion aggregates and migrates to the plasma membrane to interact with Orai1 part of the calcium release-activated calcium (CRAC) channel complex. This interaction opens the channel allowing calcium ions to flow into the cytosol which is necessary for various cellular functions such as gene expression and cell proliferation.
Pathways
STIM1 functions integrally in the calcium signaling pathway a system central to numerous physiological processes. Here STIM1 ensures appropriate calcium ion concentrations facilitate activation of various transcription factors and enzymes. It closely associates with Orai1 triggering the CRAC channel activation in response to the endoplasmic reticulum calcium levels. Additionally STIM1 interacts with other signaling molecules like protein kinase C coordinating between different pathways to maintain cellular homeostasis.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (19)
Recent publications for all applications. Explore the full list and refine your search
Cells 12: PubMed37830549
2023
Applications
Unspecified application
Species
Unspecified reactive species
Molecules (Basel, Switzerland) 28: PubMed36677874
2023
Applications
Unspecified application
Species
Unspecified reactive species
eLife 12: PubMed36625722
2023
Applications
Unspecified application
Species
Unspecified reactive species
Pathogens (Basel, Switzerland) 10: PubMed34684224
2021
Applications
Unspecified application
Species
Unspecified reactive species
Muscle & nerve 64:567-575 PubMed34368974
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cell cycle (Georgetown, Tex.) 19:3231-3248 PubMed33198579
2020
Applications
Unspecified application
Species
Unspecified reactive species
Journal of advanced research 34:173-186 PubMed35024189
2020
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 21: PubMed32245208
2020
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 21: PubMed32098295
2020
Applications
Unspecified application
Species
Unspecified reactive species
Acta biochimica et biophysica Sinica 52:207-210 PubMed31942931
2020
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com